Nosocomial urinary tract infections: Micro-organisms, antibiotic sensitivities and risk factors

West Indian Medical Journal

Volumn 55, Issue 3, 2006, Pages 188-193

  Savas, L ^a   Guvel, S ^b   Onlen, Y ^a   Savas, N ^a   Duran, N D ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZTREONAM; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; METHYLENE BLUE; NETILMICIN; NORFLOXACIN; SULTAMICILLIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLADDER CATHETERIZATION; CANDIDA; CHI SQUARE TEST; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG CHOICE; ENTEROCOCCUS; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INTENSIVE CARE UNIT; KLEBSIELLA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROORGANISM; PATIENT INFORMATION; PROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; TURKEY (REPUBLIC); URINARY TRACT INFECTION; URINE CATHETER;

EID: 33749603014     PISSN: 00433144     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0043-31442006000300011     Document Type: Article

References (32)

1. Saint S, Lipsky BA. Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med 1999; 159: 800-8.
2. Merle V, Germain JM, Bugel H, Nouvellon M, Lemeland JF, Czernichow P et al. Nosocomial urinary tract infections in urologic patients: assessment of a prospective surveillance program including 10,000 patients. Eur Urol 2002; 41: 483-9.
3. Givens CD, Wenzel RP. Catheter-associated urinary tract infections in surgical patients: A controlled study on the excess morbidity and costs. J Urol 1980; 124: 646-8.
4. Medina M, Martinez-Gallego G, Sillero-Arenas M, Delgado-Rodriguez M. Risk factors and length of stay attributable to hospital infections of the urinary tract in general surgery patients. Enferm Infecc Microbiol Clin 1997; 15: 310-4.
5. Mulhall AB, Chapman RG, Crow RA. Bacteriuria during indwelling urethral catheterization. J Hosp Infect 1988; 11: 253-62.
6. Stamm WE. Nosocomial urinary tract infections. In: Bennett JV, Brachman PS (eds). Hospital Infections. Third ed. Boston: Little, Brown and Co, 1992: 597-610.
7. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH et al. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee, JAMA 1995; 274: 639-44.
8. Grubenberg GN. Antibiotic sensitivities of urinary pathogens: 1971-1982. J Antimicrob Chemother 1984; 14: 17-23.
9. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29: 245-52.
10. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Sur-veillance Network Database-USA. Clin Infect Dis 1999; 29: 259-63.
11. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27: 520-32.
12. Winstanley TG, Limb DI, Eggington R, Hancock F. A 10 year survey of the antimicrobial susceptibility of urinary tract isolates in the UK: The Microbe Base project. J Antimicrob Chemother 1997; 40: 591-4.
13. Trienekens T, Stobberingh E, Beckers F, Knottnerus A. The antibiotic susceptibility patterns of uropathogens isolated from general practice patients in southern Netherlands. J Antimicrob Chemother 1994; 33: 1064-6.
14. Garau J, Xercavins M, Rodriguez-Carballeria M, Gomez-Vera JR, Coll I, Vidal D et al. Emergence and dissemination of quinolone-resistant Eschenchia coli in the community. Antimicrob Agents Chemother 1999; 43: 2736-41.
15. Aguiar JM, Chacon J, Canton R, Baquero F. The emergence of highly fluoroquinolone-resistant Escherichia coh in community-acquired urinary tract infections. J Antimicrob Chemother 1992; 29: 349-50.
16. Beck-Sague CM, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 1993; 167: 1247-51.
17. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (suppl 3B): 72S-75S.
18. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
19. Tolkoff-Rubin NE, Cotran RS, Rubin RH. Urinary tract infection, pyelonephritis and reflux nephropathy. In: Brenner BM, (editor) Brenner & Rector's - The Kidney, 6th ed Vol 11 Philadelphia: WB Saunders; 2000: 1449-508.
20. Collee JG, Miles RS, Watt B. Tests for the identification of bacteria. In: Collee JG, Fraser AG, Marmion BP, Simmons A (editors). Mackie and McCartney. Practical Medical Microbiology 14th ed. London: Churchill Livingstone 1996: 131-45.
21. National committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests NCCLS document M2-A7, Approved Standard, 7th edition: Wayne, PA: NCCLS, 2000.
22. Bronsema DA, Adams JR, Pallares R, Wenzel RP. Secular trends in rates and etiology of nosocomial urinary tract infections at a university hospital. J Urol 1993; 150: 414-6.
23. Wong ES, Guideline for prevention of catheter-associated urinary tract infection. Am J Infect Control 1983; 11: 28-36.
24. Kirby RR, Taylor RW, Civetta JM. Nosocomial infection. In. Handbook of Critical Care. 2nd ed. Philadelphia (PA): Lippincott-Raven; 1997: 821-31.
25. Edmond MB, Wenzel RP. Organization for infection control. In: Mandell GL Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed Philadelphia: Churchill Livingstone, 2000: 2988-91.
26. Khurana CM, Wojack BR. Prevalence of ciprofloxacin resistance in multi resistant Gram negative intensive care unit isolates. Infection 1994; 22 (Suppl 2): S99-104.
27. Snydman DR. Clinical implications of multi-drug resistance in the intensive care unit. Scant J infect Dis 1991; 78: 54-63.
28. Haley RW, Culver DH, White JW, Morgan WM, Emori TG, Munn VP et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121: 182-205.
29. Lizioli A, Privitera G, Alliata E, Antonietta Banfi EM, Boselli L, Panceri ML et al. Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000. J Hosp Infect 2003; 54: 141-8.
30. Leblebicioglu H, Esen S. Turkish Nosocomial Urinary Tract Infection Study Group. Hospital-acquired urinary tract infections in Turkey: a nationwide multicenter point prevalence study. J Hosp Infect 2003; 53: 207-10.
31. Bryan CS, Reynolds KL. Hospital-acquired bact aemic urinary infection: epidemiology and outcome. J Urol 1984; 13 : 494-8.
32. Turck M, Stamm W. Nosocomial infection of the urinary tract. Am J Med 1981; 70: 651-4.